Alligator Bioscience AB Financial Overview
Alligator Bioscience AB's market cap is currently kr224.11M. The company's EPS TTM is kr-0.096; its P/E ratio is -0.16; Alligator Bioscience AB is scheduled to report earnings on October 23, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
